Lataa...
CRISPR/Cas9: From Genome Engineering to Cancer Drug Discovery
Advances in translational research are often driven by new technologies. The advent of microarrays, next-generation sequencing, proteomics and RNA interference (RNAi) have led to breakthroughs in our understanding of the mechanisms of cancer and the discovery of new cancer drug targets. The discover...
Tallennettuna:
| Julkaisussa: | Trends Cancer |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5461962/ https://ncbi.nlm.nih.gov/pubmed/28603775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trecan.2016.05.001 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|